Enhanced expression of renal endothelin-converting enzyme-1 and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation

被引:27
作者
Feldman, DL [1 ]
Mogelesky, TC [1 ]
Chou, M [1 ]
Jeng, AY [1 ]
机构
[1] Novartis Pharmaceut Corp, Metab & Cardiovasc Dis, Summit, NJ 07901 USA
关键词
endothelin-converting enzyme-1 (ECE-1); endothelin-A (ETA); ureter ligation; interstitial injury/fibrosis;
D O I
10.1097/00005344-200036001-00075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelin-1 (ET-1) has been implicated in many chronic renal glomerular diseases. The purpose of this study was to investigate whether the levels of mRNA expression of endothelin-converting enzyme-1 (ECE-1) and endothclin-A- and -B- (ETA and ETB) receptors are altered during the: progression of interstitial fibrosis following ureter ligation. Rats were subjected to left ureter ligation or a sham operation and euthanized 5 days afterward. Kidneys were fixed in Carnoy's Fixative, embedded in paraffin, and sectioned for assessment of interstitial fibrosis by staining for collagen III using immunofluorescence techniques. The area occupied by collagen staining was quantified by image analysis. Kidneys from obstructed rats showed a 54% increase in the area occupied by collagen III sraining compared to the contralateral kidney, and an 89% increase compared to sham-operated kidneys. The mRNA levels of ECE-1, as well as ETA- and ETB-receptors in the kidney were analyzed by Northern blots. It was found that the ECE-1 and ETA-receptor mRNA levels in kidneys subjected to ureter ligation increased by 92% and 71%, respectively, when compared with those obtained from the contralateral kidneys. In contrast, mRNA levels of ETB-receptors were not significantly different between the two groups. These results suggest that ET-1, through interaction with the ETA-receptors, may play a role in the progression of interstitial fibrosis following ureter ligation.
引用
收藏
页码:S255 / S259
页数:5
相关论文
共 20 条
[1]   Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney [J].
Benigni, A ;
Zoja, C ;
Corna, D ;
Orisio, S ;
Facchinetti, D ;
Benatti, L ;
Remuzzi, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :416-423
[2]   A SPECIFIC ENDOTHELIN SUBTYPE-A RECEPTOR ANTAGONIST PROTECTS AGAINST INJURY IN RENAL-DISEASE PROGRESSION [J].
BENIGNI, A ;
ZOJA, C ;
CORNA, D ;
ORISIO, S ;
LONGARETTI, L ;
BERTANI, T ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1993, 44 (02) :440-444
[3]  
BENIGNI A, 1995, MINER ELECTROL METAB, V21, P283
[4]  
DIAMOND JR, 1995, AM J PATHOL, V146, P1455
[5]  
DIAMOND JR, 1994, AM J PHYSIOL, V226, pF926
[6]   Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension [J].
Hocher, B ;
ThoneReineke, C ;
Rohmeiss, P ;
Schmager, F ;
Slowinski, T ;
Burst, V ;
Siegmund, F ;
Quertermous, T ;
Bauer, C ;
Neumayer, HH ;
Schleuning, WD ;
Theuring, F .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1380-1389
[7]   Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy [J].
Ishidoya, S ;
Morrissey, J ;
McCracken, R ;
Klahr, S .
KIDNEY INTERNATIONAL, 1996, 49 (04) :1110-1119
[8]   ANGIOTENSIN-II RECEPTOR ANTAGONIST AMELIORATES RENAL TUBULOINTERSTITIAL FIBROSIS CAUSED BY UNILATERAL URETERAL OBSTRUCTION [J].
ISHIDOYA, S ;
MORRISSEY, J ;
MCCRACKEN, R ;
REYES, A ;
KLAHR, S .
KIDNEY INTERNATIONAL, 1995, 47 (05) :1285-1294
[9]  
ISHIMURA E, 1991, Journal of the American Society of Nephrology, V2, P546
[10]   LONG-TERM COMPLETE URETERAL OBSTRUCTION IN THE YOUNG-RAT [J].
JOSEPHSON, S ;
HEMSEN, A .
UROLOGIA INTERNATIONALIS, 1994, 53 (02) :57-61